Stanford University
Showing 11,001-11,050 of 35,030 Results
-
Angel Gunaman
Office Aide, Contingent
Undergraduate, Management Science and Engineering
Undergraduate, Mechanical EngineeringBioI'm a Mechanical Engineering major at Stanford, concentrating in Product Realization and minoring in Management Science & Engineering. I'm passionate about building meaningful technology and have experience in engineering research, product development, and public sector infrastructure.
-
Susanna Gunamany
Postdoctoral Scholar, Urology
BioDr. Gunamany received her PhD in Public Health from the Indian Institute of Technology (IIT) Gandhinagar. Before her doctoral studies, she earned a Master of Public Health (MPH) degree from the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India, and a Bachelor of Science from the University of Kerala.
Dr. Gunamany's scholarly pursuits revolve around the convergence of health and technology, with a specific emphasis on mobile health (mHealth) and its potential for improving healthcare delivery and access. Broadening her research scope, she is interested in health disparities and inequalities research, focusing on marginalized populations and the intricate interplay of social, economic, and environmental factors influencing health outcomes. -
Ruwan Gunaratne
Instructor, Medicine - Hematology
BioRuwan Gunaratne, MD, PhD is an Instructor in Hematology at Stanford University School of Medicine and a board-certified hematologist-oncologist with a clinical focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). His clinical and translational research centers on improving disease monitoring in myeloid cancers using personalized circulating tumor DNA (ctDNA) profiling, a blood-based approach designed to more sensitively track measurable residual disease (MRD), assess treatment response, refine risk stratification, and detect relapse earlier across the myeloid disease spectrum. Dr. Gunaratne’s work has been recognized with awards from the American Society of Hematology and the Stanford Cancer Institute, and he is actively committed to advancing precision medicine approaches for patients with myeloid malignancies.
-
Siddharth Gundapaneni
Research Analyst for State and Local Government Initiative, HOOVER RESEARCH
Current Role at StanfordResearch Analyst at The Hoover Institution's State and Local Governance Initiative
-
Mary Gunn
Affiliate, Stanford Online High School
BioMary Gunn, PhD, MBA, LLM, is a Chair, Non-Executive Director, Advisory Board Member, and CEO with over two decades of governance and executive leadership experience across technology-enabled, innovation-led businesses, financial services, and global enterprises.
She brings deep experience in scaling companies from early-stage through global expansion, working closely with founders, management teams, and investors on capital allocation, operating model design, commercialization, and value creation.
At board level, Mary supports strategy formulation, investment oversight, and governance build-out, with particular strength in navigating complex environments including rapid scaling, operational reset, cross-border expansion, and shareholder activism. She has served across audit/risk, nomination/compensation, and investment committees, with a focus on aligning long-term value creation with disciplined execution.
Mary is currently a board director of FTSE 250 listed Edinburgh Worldwide Investment Trust (EWI:LSE), an innovation-focused global investment trust investing across public and private markets, and several growth-stage companies. She also serves on the business, investment, and international committees of the University of Edinburgh, including the Investment Committee of Old College Capital, overseeing a portfolio of 100+ venture-stage companies across technology, climate, and life sciences.
She has advised private equity, venture capital, and corporate development teams for over a decade, supporting the deployment of $20B+ across 150+ investments. Her role has consistently focused on bridging investment strategy with execution, particularly in situations requiring hands-on operational leadership.
As a global C-level executive and interim CEO, Mary has overseen multi-billion-dollar portfolios, large international teams, and operations across up to 75 countries, with a track record of driving growth, transformation, and successful exits. -
Matthew Gunther, MD, MA
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on improving psychiatric care for medically complex patients through integrated behavioral health, medical education, and consultation-liaison psychiatry, with particular emphasis on psychiatry-led education for internal medicine residents, psychiatric interviewing, trauma-informed communication, delirium, catatonia, and psychopharmacology in the medically ill.
-
H. Henry Guo, MD, PhD
Clinical Professor, Radiology
Current Research and Scholarly InterestsQuantitative CT
AI assisted radiology interpretation
PET imaging of lung diseases
CT imaging biomarkers heart and lung diseases
Quality assurance of ultralow dose CT scans
Post radiation treatment changes of lung tumors
3D printing
